Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Sanofi-Aventis to Buy Firms in Brazil and U.S.
8:49 AM MDT | April 24, 2009 | DEEPTI RAMESH
Sanofi-Aventis (Paris) says it has agreed to acquire Medley (Campinas, Brazil), Brazil’s largest generics drugmaker and third-largest pharmaceutical company, for about €500 million ($650 million). Separately, Sanofi-Aventis has inked a deal to acquire BiPar Sciences (Brisbane, CA), a privately held biopharma company, for up to $500 million, depending on the achievement of certain milestone payments. Both transactions are expected to close this quarter. The Medley deal will enable Sanofi-Aventis to become the leading player in generics in Brazil and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee